News and Updates for Healthcare Professionals

Ischemic and hemorrhagic strokes lead to significant disability but, most important, are preventable. The 2024 primary prevention of stroke guideline provides recommendations based on current evidence for strategies to prevent stroke throughout the life span. These recommendations align with the American Heart Association’s Life’s Essential 8 for optimizing cardiovascular and…

AHRQ’s growing effort to address steep challenges in the delivery of high-quality primary care is the subject of a new AHRQ Views blog post. In the U.S. today, primary care clinicians are battling burnout, and patients are losing access to high-quality coordinated, comprehensive, and continuous care. As we celebrate National…

MADRID — Individuals with type 2 diabetes and/or obesity plus one or more metabolic risk factors are at a higher risk for metabolic dysfunction–associated steatotic liver disease (MASLD) with fibrosis and progression to more severe liver disease, stated new European guidelines that provide recommendations for diagnosis and management.

Guidelines evaluate and summarize available evidence with the aim of assisting health professionals in proposing the best diagnostic or therapeutic approach for an individual patient with a given condition. Guidelines are intended for use by health professionals and the European Society of Cardiology (ESC) makes its Guidelines freely available.

Guidelines evaluate and summarize available evidence with the aim of assisting health professionals in proposing the best diagnostic or therapeutic approach for an individual patient with a given condition. Guidelines are intended for use by health professionals and the European Society of Cardiology (ESC) makes its guidelines freely available.

Heart failure (HF) affects nearly 6.7 million Americans, and its prevalence continues to increase.1-3 Inpatient admissions for HF are associated with high mortality, and readmissions and subsequent health events are common.4,5 Although symptoms often improve rapidly during HF hospitalization, episodes of worsening HF nevertheless may mark a fundamental change in…

As life expectancies increase, the number of people living with dementia worldwide continues to rise. The 2024 report of the Lancet Commission on dementia prevention, intervention, and care adds compelling new evidence that untreated vision loss and high LDL cholesterol are risk factors for dementia. Overall, around 45% of cases…

Unhealthy alcohol use increases the risk for and exacerbation of chronic health conditions. As such, screening, prevention, and management of unhealthy alcohol use is especially critical to improving health outcomes for patients with multiple chronic health conditions.

What if there were tests that could tell you whether the following drugs were a good match for your patients: Antidepressants, statins, painkillers, anticlotting medicines, chemotherapy agents, HIV treatments, organ transplant antirejection drugs, proton pump inhibitors for heartburn, and more? That’s quite a list. And that’s pharmacogenetics, testing patients for…

AHRQ’s ongoing research investments in clinical decision support (CDS) and its potential to help clinical teams recommend the latest evidence-based medicine to patients is the subject of a new AHRQ Views blog post. AHRQ’s Digital Healthcare Research Program has supported CDS research, implementation, and demonstration projects throughout its 20-year history.…